DA
KURA icon

Denali Advisors’s Kura Oncology KURA Stock Holding History

Denali Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,000
Closed -$82.1K – 481
2023
Q3 		$82.1K Hold
9,000
– – 0.03% 280
2023
Q2 		$95.2K Hold
9,000
– – 0.03% 268
2023
Q1 		$110K Buy
9,000
+5,200
+137% +$64.9K 0.05% 175
2022
Q4 		$47.2K Sell
3,800
-2,700
-42% -$39.2K 0.02% 232
2022
Q3 		$89K Hold
6,500
– – 0.04% 172
2022
Q2 		$119K Buy
6,500
+2,700
+71% +$38.8K 0.05% 163
2022
Q1 		$61K Hold
3,800
– – 0.02% 226
2021
Q4 		$53K Buy
+3,800
New +$61.6K 0.02% 242

Other funds holding KURA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Denali Advisors's KURA Position: Q4 2023 in Review

Denali Advisors sold out of Kura Oncology (KURA) in Q4 2023, closing a stake of 9,000 shares — an estimated $82.1K sold.

Denali Advisors first reported a position in KURA in Q4 2021 and held it in 8 quarters. The position peaked at $119K in Q2 2022. 140 funds tracked by Wall St. Rank hold KURA as of Q4 2023.

  • Denali Advisors reported no remaining Kura Oncology position as of Q4 2023 after selling out during the quarter.
  • Denali Advisors sold 9,000 Kura Oncology shares in Q4 2023, an estimated $82.1K.
  • Denali Advisors first reported a position in Kura Oncology in Q4 2021 and held it in 8 quarters.
  • Denali Advisors's Kura Oncology position peaked at $119K in Q2 2022.
  • 140 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2023.

Based on Denali Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.